Barely Significant
← all excerpts

Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases.

Int J Mol Sci · 2023 · PMC10179505 · PMID 37176018

1
hedged sentence
closest p
boldest claim

The sentences

may not be significantno p-value reported
Thus, competition for copper between these hybrids and the A β peptide may not be significant, and so the inhibition process must be mostly regulated by the capacity of ligand intercalation between β-sheets of A β fibrils.

also in 882 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.